Grace Colon serves as Executive at CareDx, Inc., where they oversee executive responsibilities. Since joining the company, Grace Colon has executed 10 insider transactions totaling $229.9K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 16, 2023 involved receiving (via award) 18,844 shares valued at $0.
Grace Colon currently holds 23,708 shares of CareDx, Inc. (CDNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Grace Colon has been a net seller of CDNA stock. They have purchased $0 and sold $229.9K worth of shares.
Grace Colon's most recent insider trade was on Jun 16, 2023, when they sold 18,844 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $24.81 |
| Discretionary |
| Jun 16, 2022 | CDNA | $0 | Award | 4,863 | $N/A | Discretionary |
| May 11, 2022 | CDNA | $119.2K | Sale | 5,179 | $23.01 | Discretionary |
| Mar 9, 2022 | CDNA | $48.1K | Sale | 1,393 | $34.56 | Discretionary |
| Jun 16, 2021 | CDNA | $0 | Award | 1,127 | $N/A | Discretionary |
| Jun 18, 2020 | CDNA | $0 | Award | 3,190 | $N/A | Discretionary |
| Jan 2, 2020 | CDNA | $0 | Award | 326 | $N/A | Discretionary |
| Oct 1, 2019 | CDNA | $0 | Award | 270 | $N/A | Discretionary |
| Jul 1, 2019 | CDNA | $0 | Award | 4,181 | $N/A | Discretionary |